Advancing Cardio-Renal-Metabolic Approaches

Advancing Cardio-Renal-Metabolic Approaches
Holiday Inn, Leicester, 5 CPD Hours
Tue 19 May 2026

Driving improved service delivery through early detection and novel CRM interventions


As Cardio-Renal-Metabolic (CRM) syndrome continues to rise, this conference provided a valuable opportunity for diabetes, cardiovascular and renal specialists, nurses and ANPs from primary, secondary and community care to come together and share best practice. By focusing on risk stratification, early detection, therapy optimisation and coordinated MDT pathways, this innovative programme explored how integrated, preventative and holistic approaches to CRM care can improve long-term outcomes for patients living with CRM conditions.


Sponsored by Novo Nordisk



Novo Nordisk and Horiba has provided sponsorship to SBK Healthcare to cover the cost of a stand at this meeting. Novo Nordisk has had no influence over the meeting agenda or arrangements, except where indicated.


Improving your practice

Enhance your knowledge with expert led, structured NHS learning


Designed to enhance early intervention, optimise patient outcomes and promote holistic practice, this unique day brought together the latest evidence and real-world examples to help embed CRM best practice into everyday service delivery by:


  • Reviewing the expanding evidence base for SGLT2s and GLP-1s across CRM conditions
  • Diagnosing and managing Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
  • Enhancing early intervention: addressing the common soil of diabetes, cardiovascular and kidney disease
  • Exploring a case study of an award-winning CRM holistic MDT model
  • Guiding therapy with natriuresis to support improved patient management
  • Understanding how frailty affects CRM risk and treatment tolerance
  • Improving functional outcomes by managing sarcopenic obesity
  • Optimising nutrition and preventing harm in weight-loss interventions

Connect, share and learn

Unpacking the latest in clinical care and multidisciplinary collaboration to improve patient outcomes


This one-day event was packed with best practice examples from expert speakers, including:


  • Expert speakers sharing clinical experience, practical tips and the latest evidence 
  • Real-world case study from award winning MDT clinic to provide the practical insights into developing a consultant-led MDT service
  • Q&A sessions with leading clinicians and pioneers

With thanks to the sponsor

SBK Healthcare would like to thank Novo Nordisk for sponsoring this unique forum. 



Novo Nordisk and Horiba has provided sponsorship to SBK Healthcare to cover the cost of a stand at this meeting. Novo Nordisk has had no influence over the meeting agenda or arrangements, except where indicated.


With thanks to our exhibitor

Invitation to sponsor

These interactive events are a great opportunity for providers of diabetes technology and treatments to support healthcare professionals. If you sponsor a forum, you will be a fundamental part of the agenda, moderating the discussions, presenting in the dedicated ‘industry partners showcase’ plus exhibiting and networking during the break times. To find out more about all the engagement and branding opportunities available in the full sponsorship package, please email Vanessa Pearce or call Vanessa on 01732 897788.

Supported by


8:30
Registration, networking and refreshments
9:00
Chair’s opening remarks
Professor Godwin Simon, Site Medical Director and Consultant Diabetes Endocrinology, Barking Havering Redbridge University Hospitals NHS Trust
The nature of cardiovascular, renal and metabolic disease
9:10
How heart, kidney and metabolic diseases interact to increase risk and long-term complications
  • Aligning with NICE NG28 recommendations: recognising heart failure risk in diabetes and implications for long-term CRM outcomes
  • Overview of the expanding evidence base for SGLT2s and GLP-1s across CRM conditions
  • Understanding how CVD manifests in patients with CKD and diabetes (T1 and 2)
Professor Godwin Simon, Site Medical Director and Consultant Diabetes Endocrinology, Barking Havering Redbridge University Hospitals NHS Trust
Improving outcomes in CRM patients: frailty and nutrition
9:35
Adapting CRM care for frail patients
  • Understanding frailty: how it affects CRM risk and treatment tolerance
  • Managing sarcopenic obesity: applying strategies to preserve muscle mass, optimise metabolic health and improve functional outcomes
  • Navigating GLP-1 therapy in frail individuals in line with NG28 recommendations for individualised care and CV risk reduction
Professor Thomas Barber, Consultant Endocrinologist and Professor of Endocrinology, University of Warwick and University Hospitals Coventry and Warwickshire
10:00
Questions and answers with your speakers
10:10
Optimising nutrition and preventing harm in weight-loss interventions
  • Nutrition support strategies across community and MDT care: recognising nutritional red flags
  • Assessing nutrition and dietary intake to maximise benefit and minimise GLP-1 associated weight loss
  • Recognising when to pause or stop weight-loss therapies based on nutritional decline
Frank Arsenyadis, Obesity/Diabetes Researcher & Dietitian, Leicester Diabetes Centre, University of Leicester and University Hospitals Leicester NHS Trust
10:35
Questions and answers with Frank Arsenyadis
10:45
Reducing Residual Cardiovascular Risk in People with Established CVD and BMI ≥27 kg/m2
Alun Roebuck, Senior Consultant Nurse in Cardiology at the Lincolnshire Heart Centre, Lincoln, UK
11:05
Questions and answers with the industry partners
11:10
Networking break
Early and integrated MDT care in CRM
11:30
Enhancing early intervention and working within NG28 guidelines: addressing the common soil of diabetes, cardiovascular and kidney disease
  • Using online platforms to support GPs and community clinicians
  • Identifying high-risk patients through comprehensive risk factor assessment
  • Ensuring timely referral to specialist teams via clear criteria to enable early detection and intervention
Donna Sutton, Lead Community Diabetes Specialist Nurse, Newcastle Upon Tyne Hospitals NHS Foundation Trust
11:55
Case study: Secondary Prevention Service recognised with HSJ Award for holistic CRM care
  • Practical insights: bringing together an MDT consultant-led team
  • Using evidence-based medical treatments to help patients achieve recommended targets
  • Providing personalised treatment and support to improve medication adherence in the early months after a cardiovascular event
Jonathan Fenwick, Senior Clinical Pharmacist, Lipid Management and Secondary Prevention, Gateshead Health NHS Foundation Trust
12:20
Questions and answers with Donna Sutton and Jonathan Fenwick
12:30
Interactive discussion: Practical challenges and solutions in CRM management

On your tables, this is an opportunity to discuss:

  • How does heart failure, CKD and metabolic disease influence your treatment priorities in practice?
  • How do you decide between, or combine, SGLT2s and GLP-1s in patients with diabetes, CKD and CVD? What barriers do you encounter? How do you overcome this?
  • How can you work collaboratively in the MDT to intervene and determine risk early on?
12:50
Networking lunch
Guiding CRM therapy: ensuring optimisation and patient safety
1:50
Guiding therapy with natriuresis to support improved patient management
  • Assessing urinary sodium as a biomarker to evaluate response to diuretic therapy
  • Using natriuretic response to inform individualised treatment decisions
  • Supporting effective fluid management and decongestion, contributing to timely and safe discharge
Professor Sandip Mitra, Senior NHS Consultant, Manchester University Hospitals NHS Foundation Trust
2:15
Questions and answers with your speaker
2:25
Translating evidence into practice: SGLT2s and GLP-1s
  • Practical implementation of GLP-1s in cardiometabolic and obesity management
  • Navigating prescribing across primary, community and specialist care
  • Positioning gliptins within modern CRM pathways alongside SGLT2s and GLP-1s
  • Discussing evidence for GLP-1s in Heart Failure with preserved Ejection Fraction (HFpEF): symptom burden, weight, inflammation and patient selection
Amy Morrison, Consultant Endocrinologist, University Hospitals of Leicester NHS Trust
2:50
Questions and answers with your speaker
3:00
Networking break
3:20
Interactive discussion: Applying CRM therapies

On your tables, this is an opportunity to discuss:

  • How do you approach patient education and adherence?
  • What challenges arise when coordinating treatment across primary, community, and specialist care? How do you overcome this?
  • How do you manage gliptin therapy as renal function declines?
  • How do weight reduction and inflammation influence your decision-making around GLP-1 use in patients with HFpEF?
3:40
The liver in CRM care: diagnosing and managing Metabolic dysfunction-Associated Steatotic Liver Disease (MASLD)
  • Considering MASLD as a core CRM condition
  • Identifying MASLD in CRM patients: diagnosis, risk stratification and red flags
  • Emerging therapies for MASLD and how they intersect with GLP-1s, SGLT2s and weight-based strategies
  • Implications for MDT care and referral pathways
Professor Samuel Seidu, Professor in Primary Care, Diabetes and Cardio-metabolic Medicine, University of Leicester
4:05
Questions and answers with Professor Samuel Seidu
4:15
Chairs closing remarks

Novo Nordisk and Horiba has provided sponsorship to SBK Healthcare to cover the cost of a stand at this meeting. Novo Nordisk has had no influence over the meeting agenda or arrangements, except where indicated.

With thanks to the expert speakers:

This conference beought together CRM professionals to highlight the value of a joint approach and showcase best practice in treating and supporting patients with CRM conditions. We heard from:  

Donna Sutton

Lead Community Diabetes Specialist Nurse
The Newcastle Upon Tyne Hospitals NHS Foundation Trust

Jonathan Fenwick

Senior Clinical Pharmacist, Lipid Management and Secondary Prevention
Gateshead Health NHS Foundation Trust

Professor Samuel Seidu

Professor in Primary Care, Diabetes and Cardio-Metabolic Medicine
University of Leicester

Professor Thomas Barber

Consultant Endocrinologist and Professor of Endocrinology
University of Warwick and University Hospitals Coventry and Warwickshire

Frank Arsenyadis

Obesity/Diabetes Researcher & Dietitian
Leicester Diabetes Centre, University of Leicester and University Hospitals Leicester NHS Trust

Amy Morrison

Consultant Endocrinologist
University Hospitals of Leicester NHS Trust

Professor Sandip Mitra

Senior NHS Consultant
Manchester University Hospitals NHS Foundation Trust

Professor Godwin Simon

Site Medical Director and Consultant Diabetes Endocrinology
Barking Havering Redbridge University Hospitals NHS Trust
user icon

Alun Roebuck

Senior Consultant Nurse in Cardiology
Lincolnshire Heart Centre, Lincoln, UK


Novo Nordisk and Horiba has provided sponsorship to SBK Healthcare to cover the cost of a stand at this meeting. Novo Nordisk has had no influence over the meeting agenda or arrangements, except where indicated.

Learn and connect

The event was ideal for healthcare professionals across primary, secondary, and community care. This engaging face to face conference equipped the attendees with the tools to deliver more integrated and efficient care, with a better understanding of the connected nature of CRM conditions. We were joined by the likes of:

  • Diabetes Specialists, Nurses and Consultants
  • Cardiology Specialists, Consultants, Nurses and Advanced Nurse Practitioners
  • Renal Specialists, Consultants, Nurses and Advanced Nurse Practitioners
  • Community pharmacists
  • Consultants in Diabetes and Endocrinology
  • Dietitians

Past attendee feedback

Advancing Cardio-Renal-Metabolic Approaches followed the success of the November 2025 webinar, ‘Delivering Integrated Care for CRM: Early Detection and Intervention in Practice’, which drew over 150 attendees and was praised as “brilliant” and “informative.” Discover what the community had to say:

quote icon
“Informative and practical”
- Delivering Integrated Care for CRM: Early Detection and Intervention in Practice, 2025
quote icon
“Very insightful, good understanding of managing complex conditions and medications to use”
- Delivering Integrated Care for CRM: Early Detection and Intervention in Practice, 2025
quote icon
“Well-presented and informative”
- Delivering Integrated Care for CRM: Early Detection and Intervention in Practice, 2025
quote icon
"Great networking opportunity. It was good to hear the different approaches being adopted by various teams and exchange ideas "
- Optimising Hybrid Closed Loop Systems: Training Workshops, London, 2025
quote icon
“Amazing, so good to address obesity in the context of current trends, research, funding and weight loss drugs”
- Foundations of Obesity Management: From First Consultations to Long Term Support, 2025
quote icon
“Very well organised with fantastic speakers”
- Foundations of Obesity Management: From First Consultations to Long Term Support, 2025

With thanks to the sponsor


Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat serious chronic diseases, built upon our heritage in diabetes.

Novo Nordisk and Horiba has provided sponsorship to SBK Healthcare to cover the cost of a stand at this meeting. Novo Nordisk has had no influence over the meeting agenda or arrangements, except where indicated.

With thanks to the exhibitor

Why sponsor?

Our role at SBK Healthcare is to bring industry together with healthcare professionals so that you can educate and inform your audience. These trail-blazing diabetes delivery forums offering dedicated presentation, Q&A, networking and discussion time, each sponsor will be full immersed into the event and able to effectively engage with your NHS audience.

quote icon
‘Always a pleasure to attend an SBK event! Great staff, great organisation and always well attended by industry and HCPs’.
- Air Liquide, Diabetes Developments National Networking Forum, Belfast
quote icon
'Brilliant event that gives clinicians and industry the opportunity to discuss current ‘hot topics’ together, collaboratively.'
- Menarini, Diabetes Developments National Networking Forum, Birmingham
quote icon
'Given a great opportunity to reach out to people who we would not normally have access to.'
- Lilly, Diabetes Developments National Networking Forum, Birmingham

Your event, managed by us

SBK Healthcare also provides in-house forums. Working closely with you as the client we can research, produce, market and deliver the conference or online forum that best suits the audience and meets your goals.

Reach out today

If you would like more information on our sponsorship options an in-house forum or if you wish to discuss your needs and what solutions may be appropriate for your business, please contact:

Vanessa Pearce
Telephone: 01732 897788
Email: vanessa.pearce@sbk-healthcare.co.uk

Please login to access documentation associated with the event. This is an exclusive benefit for all of the attendees and includes additional and updated documentation.